期刊文献+

基于STM32芯片的肿瘤细胞荧光检测系统设计 被引量:4

Design of tumor cell fluorescence detection system based on STM32 chip
下载PDF
导出
摘要 为了实现肿瘤细胞早期筛查以达到早期防治,本研究开发了一种基于微流控芯片的肿瘤细胞荧光检测系统。光路采用反射式共焦距光路结构;硬件电路基于光电探测器模块、STM32F103C8T6、A/D转换芯片与串口芯片对激发荧光信号实时采集,并向上位机传输。同时设计了一套基于荧光检测的软件系统,实现检测动态可视化与报告生成及打印功能。采用FITC荧光素标记的乳腺癌细胞MDA-MB-453进行试验。结果表明,该系统在6 mL/h最佳进样速度下,对肿瘤细胞的平均检测率达到85.36%,为临床的应用提供可靠的诊断方法。 In order to achieve early screening of tumor cells for early prevention and control,We developed a tumor cell fluorescence detection system based on microfluidic chip.The optical path adopted a reflective confocal optical path structure;the hardware circuit was based on the photodetector module,STM32F103C8T6,A/D conversion chip and serial port chip,realized real-time acquisition of the excited fluorescent signal and transmission to the upper computer.At the same time,a software system based on fluorescence detection was designed to realize the dynamic visualization and the report generation and printing functions.The FITC-labeled breast cancer cell MDA-MB-453 was used to test the system.The results show that the average detection rate of tumor cells reach 85.36%at the optimal injection speed of 6 mL/h,which provides reliable diagnostic methods for clinical application.
作者 纪春阳 徐秀林 JI Chunyang;XU Xiulin(School of Medical Instrument and Food Engineering,University of Shanghai for Science and Technology,Shanghai 200093,China)
出处 《生物医学工程研究》 2020年第1期79-83,共5页 Journal Of Biomedical Engineering Research
基金 上海市科委科技支撑计划资助项目(19441904500)。
关键词 STM32芯片 微流控芯片 肿瘤细胞 荧光检测 光电转换 软件设计 STM32 Micro-fluidic chip Tumor cell Fluorescence detection Photoelectric conversion Software design
  • 相关文献

参考文献1

二级参考文献32

  • 1Kurtz JE, Dufour P. Adecatumumab : an anti-EpCAM monoclonal antibody, from the bench to the bedside[J]. Expert Opin Biol Ther, 2010, 10(6) :951-958.
  • 2Trzpis M, McLaughlin PM, de Leij LM, et al. Epithelial cell ad- hesion molecule. More than a carcinoma marker and adhesion mol- ecttle[J. Am J Pathol, 2007, 171(2) : 386-395.
  • 3Herlyn M, Steplewski Z, Herlyn D, et al. Colorectal carcinoma- specific antigen : detection by means of monoclonal antibodies[J]. Pro Nat1 Acad Sci U S A, 1979, 76(3) :1438-1442.
  • 4Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer[Jl. BrJ Cancer, 2007, 96(3) :417-423.
  • 5van der Gun BT, Melchers LJ, Ruiters MH, et al. EpCAM in carcinogenesis: the Good, the Bad or the Ugly[J]. Carcinogene- sis, 2010, 31(11) :1913-1921.
  • 6Munz M, Baeuerle PA, Gires O, et al. The emerging role of EpCAM in cancer and stem cell signaling[J]. Cancer Res, 2009, 69(14) :5627-5629.
  • 7Le Naour F, Zoller M. The tumor antigen epcam: tetraspanins and the fight junction protein claudin-7, new partners, new func- tions[J], Front Biosci, 2008, 13:5847-5865.
  • 8Chaudry MA, Sales K, RufP, et al. EpCAM an immunothera- peutic target for gastrointestinal malignancy: current experience and future challenges[J]. Br J Cancer, 2007, 96(7) : 1013-1019.
  • 9Khan MS, Tsigani T, Rashid M, et al. Circulating tumor cells and EpCAM expression in neuroendocrine tumors [ J ]. Clin Cancer Res, 2011, 17(2) :337-345.
  • 10Klein CE, Cordon-Cardo C, Soehnchen R, et al. Changes in cell surface glycoprotein expression during differentiation of human ke- ratinocytes [ J ]. J Invest Dermatol, 1987, 89 (5) :500-506.

共引文献4

同被引文献49

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部